top of page
.png)
Cell and Gene Therapy Updates
May 3rd Week, 2025 ⭐ Regulatory Update 🎯 The US FDA granted the RMAT designation to BrainChild Bio ’s BCB-276 (an autologous, B7-H3...
Oncofocus Team
6 days ago2 min read
2 views
Targeting the PD-1/PD-L1 immunosuppressive axis: CAR-T strategies under investigation
PD-(L)1 axis inhibits CAR-T cell activation, proliferation, survival, and functionality. Thus, CAR-T mediated direct targeting of the...
Oncofocus Team
Jan 11, 20241 min read
385 views
bottom of page